Clinical Trial Update: Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy [Phase 2, Phase 3]

View source ↗

Summary

A terminated Phase 2/3 clinical trial evaluating obeticholic acid versus placebo in pediatric biliary atresia patients after hepatoportoenterostomy, assessing e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Atresia

Drugs mentioned

• Ocaliva (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Biliary Atresia | Phase 2, Phase 3 | Status: TERMINATED